The latest closing stock price for OncoCyte as of November 20, 2024 is 2.75.
An investor who bought $1,000 worth of OncoCyte stock at the IPO in 2016 would have $-985 today, roughly -1 times their original investment - a -37.16% compound annual growth rate over 9 years.
The all-time high OncoCyte stock closing price was 202.20 on January 05, 2016.
The OncoCyte 52-week high stock price is 4.30, which is 56.4% above the current share price.
The OncoCyte 52-week low stock price is 2.29, which is 16.7% below the current share price.
The average OncoCyte stock price for the last 52 weeks is 3.00.
An investor who bought $1,000 worth of OncoCyte stock at the IPO in 2016 would have $-985 today, roughly -1 times their original investment - a -37.16% compound annual growth rate over 9 years.
The all-time high OncoCyte stock closing price was 202.20 on January 05, 2016.
The OncoCyte 52-week high stock price is 4.30, which is 56.4% above the current share price.
The OncoCyte 52-week low stock price is 2.29, which is 16.7% below the current share price.
The average OncoCyte stock price for the last 52 weeks is 3.00.